Why is "Influenza vaccine" trending?

Search Interest Perspective

• Interim Clinical Considerations for the Use of Seasonal Influenza Vaccines in the United States - Centers for Disease Control and Prevention | CDC (.gov)
• CSL Seqirus' adjuvanted flu vaccine wins Korean nod for adults aged 50 and older - Korea Biomedical Review
• GSK's mRNA Influenza Vaccine Moves to Phase 3 Trial - Contagion Live
• Recombinant Flu Vaccine Cuts Nursing Home Outbreaks - Medscape
• GSK to Advance mRNA Influenza Vaccine Into Phase III Development - Yahoo Finance
• Immunogenicity and safety of seasonal influenza vaccine co-administered with other vaccines: a systematic review and meta-analysis - Nature
• Health Secretary Receives Influenza Vaccine, Urges Public to Get Vaccinated Early This Season - bastillepost.com
• mFlusiva becomes the first mRNA influenza vaccine approved by the FDA - 2 Minute Medicine
• The unharmonious 2026 child and adolescent immunization schedule - addendum - Contemporary Pediatrics
• Osivax And GC Biopharma Enter Collaboration to Develop Next Generation Influenza Vaccine - Pharmaceutical Executive
• FDA Panel Backs Moderna's mRNA-Based Influenza Vaccine for Adults 50+ - MPR - Medical Professionals Reference
• Policy Priorities to Modernize Seasonal Influenza Vaccine Development - Margolis Institute for Health Policy
• Influenza vaccine batch release project for southern hemisphere 2026 - Therapeutic Goods Administration (TGA)
• Osivax bags flu vaccine rights to pursue combination shot vision - fiercebiotech.com
• Osivax and GC Biopharma partner on next-generation combination influenza vaccine - The Pharma Letter
• AAP updates 2026-2027 pediatric influenza vaccine and antiviral recommendations - Contemporary Pediatrics
• mRNA-based influenza vaccine expands the B cell response breadth in humans - Nature
• Moderna's mFlusiva Approved as First mRNA-Based Influenza Vaccine - MPR - Medical Professionals Reference
• Poor sleep impairs immune responses and influenza vaccine protection - Nature
• Modernizing Influenza Vaccine Development: Policy Priorities for Stakeholders - Margolis Institute for Health Policy
• Korea's GC Biopharma collaborates with French firm Osivax to develop next-gen influenza vaccine - BioSpectrum Asia
• Role of High-Dose Influenza Vaccine in Reducing Cardiovascular Risk - American Heart Association Journals
• mRNA Influenza Vaccine Advances Against Multiple Strains - Contagion Live
• Phase 3 Trial Finds Moderna’s mRNA-1010 Influenza Vaccine Outperformed Standard-Dose Vaccines in Adults Aged 50 Years and Older - Applied Clinical Trials Online
• GSK plans phase 3 after mRNA flu vaccine beats standard shots - fiercebiotech.com
• Influenza vaccine responses differ between young children previously exposed to influenza antigens via infection versus vaccination - Nature
• mRNA-based Influenza Vaccine Advances Against HHS Resistance - Contagion Live
• MF59-adjuvanted A/Astrakhan influenza vaccine induces cross-neutralizing H5N1 antibodies in ferrets against circulating clade 2.3.4.4b viruses - Nature
• Recommendations for influenza vaccine composition for the 2026-2027 northern hemisphere season - World Health Organization (WHO)
• UNL researchers pioneer new swine influenza vaccine approach - National Hog Farmer
• Childhood Influenza Vaccine Rates Decreased From 2017 to 2023 - The American Journal of Managed Care
• FDA approves new mRNA flu vaccine for adults - 95.5 WSB
• Natural Experiment Supports Pediatric Influenza Vaccine Effectiveness Amid Shifting Federal Recommendations - The American Journal of Managed Care
• Influenza Vaccine Reduces Hospitalizations, But Not Mortality, in Older Adults - Docwire News
• mRNA-1010 Shows Superior Influenza Vaccine Efficacy in Adults ≥50 vs Standard Vaccines - Consultant360
• FDA Approves mFlusiva, the First mRNA-Based Influenza Vaccine - Pharmacy Times
• Singapore pushes back new flu jab rollout to mid Oct even as infections rise - Yahoo
• Efficacy, Immunogenicity, and Safety of Modified mRNA Influenza Vaccine - NEJM
• Limited evidence of AI superiority in seasonal influenza vaccine strain selection - Nature
• Public Health Alerts: Antibodies elicited by the 2025-2026 influenza vaccine - CIDRAP
• Influenza vaccine-specific CD4+ T cell responses are impaired in older adults - npj Vaccines - Nature
• Improved influenza vaccines: full value vaccine assessment - World Health Organization (WHO)
• The Flu Vaccine: Explained #influenza_vaccine Mma Fights Tonight (ns3E3UIzJk) - Mshale
• Key FDA committee unanimously recommends its first vaccine since 2023 - NPR
• PAHO signs agreement to reserve pandemic influenza vaccine supply for Latin America and the Caribbean - Pan American Health Organization (PAHO)
• FDA refuses to review Moderna's influenza vaccine application - Reuters
• Flu Vaccine Effectiveness Studies for Children and Older Adults - Centers for Disease Control and Prevention | CDC (.gov)
• Immunogenicity and protection of octavalent influenza vaccine candidates using adjuvanted proteins or mRNA-LNPs in naïve mice | npj Vaccines - Nature
• FDA Declines to Review Moderna’s mRNA Influenza Vaccine Application - Infectious Disease Advisor
• Moderna Receives U.S. FDA Approval for Influenza Vaccine mFLUSIVA - ACCESS Newswire
• Estradiol enhances influenza vaccine responses through B cell metabolic reprogramming in female mice - ASM Journals
• FDA Refuses to Review Moderna's Influenza Vaccine for Potential Approval - Contagion Live
• Advancing influenza vaccine development: Sino Biological launches antigens for the 2026-2027 Northern Hemisphere influenza vaccine strains - news-medical.net
• Immunogenicity of high-dose recombinant influenza vaccine versus standard-dose egg-grown and cell-grown vaccines among frequently and infrequently vaccinated young adults in Singapore: a randomised, controlled, double-blind, single-centre, phase 4 cli - The Lancet
• An mRNA influenza vaccine induces immunity comparable to an adjuvanted vaccine in a randomized trial - Nature
• Enhancing the breadth of protection in mice with a multivalent influenza vaccine | Communications Biology - Nature
• Osivax and GC Biopharma Enter Strategic Collaboration to Develop a Next-Generation Influenza Vaccine Combining OVX836 and GC FLU - Yahoo Finance
• Next-generation influenza vaccines could save millions of lives, finds WHO - World Health Organization (WHO)
• Flu and Children | Influenza (Flu) - Centers for Disease Control and Prevention | CDC (.gov)
• USDA recommends influenza vaccine for adults over 50; path forward is uncertain - Northern Kentucky Tribune
• MRNA Up as Influenza Vaccine Wins Unanimous FDA Advisory Panel Backing - Yahoo Finance
• Pfizer’s mRNA Influenza Vaccine Shows Superior Efficacy to Inactivated Vaccine in Phase 3 Trial - Contagion Live
• SK bioscience, IDT Biologika and Vaxxas Selected for Next-Generation Influenza Vaccine development Financed by the European Union - PR Newswire
• Hegseth: Flu Vaccine Optional - U.S. Department of War (.gov)
• Age-dependent immune landscapes affect influenza vaccine effectiveness and guide precision strategies - Frontiers
• New Swine Influenza Vaccine Technology Could Transform Hog Health Management - farms.com
• mRNA-1010 influenza vaccine elicits distinct and enhanced humoral immunity compared to adjuvanted inactivated vaccines - Nature
• Systematic review of evidence on feasibility of administering intranasal live attenuated influenza vaccine at home - Nature
• Human Challenge Trial of a Nucleoside-Modified Messenger Ribonucleic Acid Influenza Vaccine - NEJM Evidence
• Nucleoside-modified mRNA influenza vaccine more effective than standard shot in adults - 2 Minute Medicine
• Dual impact of squalene-adjuvanted influenza vaccine on immunity and glucose homeostasis in obese mice - Nature
• NDAA Amendment Mandates Influenza Vaccine After Lackland Air Force Outbreak - Military.com
• EMA: First combined COVID-19 and influenza vaccine for people 50 years and older - European AIDS Treatment Group
• CDC: Influenza vaccine during 2025 to 2026 season less effective than previous seasons - medicalxpress.com
• Reversing Course, FDA Will Now Review Moderna's Influenza Vaccine - Contagion Live
• Impact of the Influenza Vaccine on Myocardial Infarction Risk: A Systematic Review - Cureus
• Increased dose of H1N1 pandemic influenza vaccine during pregnancy improves immunity in mothers and infants - ASM Journals
• Influenza vaccine based on AS03-adjuvanted chimeric HA induces long-lived stalk-specific plasma cells in bone marrow and lymph nodes of nonhuman primates - Nature
• Can I get a free flu shot? And will it cover ‘super K’? Your influenza vaccine questions answered - The Conversation
• Influenza Vaccine Study in Older Adults Supports Flexible Vaccine Strategies for Health Systems and Long-Term Care Facilities - Infection Control Today
• WHO Recommendations for Influenza Vaccine Composition for the 2026-2027 Northern Hemisphere Influenza Season - Avian Flu Diary
• USDA Says Avian Influenza Vaccine Still in Development - Hoosier Ag Today
• Live attenuated influenza vaccine with low proportions of defective interfering particles elicits robust immunogenicity and cross-protection - Nature
• Moderna gets U.S. FDA approval for Influenza Vaccine mFLUSIVA - Chain Drug Review
• Effectiveness of High-Dose Influenza Vaccine Against Hospitalizations in Older Adults - FLUNITY-HD - American College of Cardiology
• In shift, Pentagon grants flu vaccine exceptions to military services, some federal agencies - Military Times
• US to participate in meeting on influenza vaccine composition, WHO official says - Reuters
• Moderna Receives U.S. FDA Approval for Influenza Vaccine mFLUSIVA - Yahoo Finance
• Health Min.: VACSERA to provide over 300K doses of Influenza vaccine - Egypt Today
• Chitosan nanoparticles prepared by spray drying augment the immune response to an A/H5N1 influenza vaccine in mice | Polymer Journal - Nature
• Canine Influenza Vaccine: What Is It, and Does Your Dog Need It? - PetMD
• Moderna gets funding for H5 pandemic influenza vaccine - BioPharma Dive
• FDA refuses to review Moderna’s influenza vaccine - STAT
• Integrated analysis of humoral and memory B-cell responses reveals distinct immune landscapes shaped by influenza vaccine platforms - Nature
• Report: Influenza vaccine effectiveness lower in recent months - Santa Clarita Valley Signal
• Immunodominant antibodies against hemagglutinin in ferrets following infection with 2018 to 2019 influenza vaccine strains - Nature
• Senators call for highly pathogenic avian influenza vaccine - Iowa Capital Dispatch
• Quadrivalent modRNA Influenza Vaccine Shows Superior Efficacy to Licensed Inactivated Vaccine in Phase 3 Trial - patientcareonline.com
• Australia Influenza Vaccine Market Size & Outlook, 2024-2030 - Grand View Research
• SK bioscience wins 1st UNICEF influenza vaccine contract - Korea Biomedical Review